The variability of functional MRI brain signal increases in Alzheimer’s disease at cardiorespiratory frequencies
Tuovinen, Timo; Kananen, Janne; Rajna, Zalan; Lieslehto, Johannes; Korhonen, Vesa; Rytty, Riikka; Mattila, Heli; Huotari, Niko; Raitamaa, Lauri; Helakari, Heta; Elseoud, Ahmed Abou; Krüger, Johanna; LeVan, Pierre; Tervonen, Osmo; Hennig, Juergen; Remes, Anne M.; Nedergaard, Maiken; Kiviniemi, Vesa (2020-12-09)
Tuovinen, T., Kananen, J., Rajna, Z. et al. The variability of functional MRI brain signal increases in Alzheimer’s disease at cardiorespiratory frequencies. Sci Rep 10, 21559 (2020). https://doi.org/10.1038/s41598-020-77984-1
© The Authors 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
https://creativecommons.org/licenses/by/4.0/
https://urn.fi/URN:NBN:fi-fe202101051110
Tiivistelmä
Abstract
Biomarkers sensitive to prodromal or early pathophysiological changes in Alzheimer’s disease (AD) symptoms could improve disease detection and enable timely interventions. Changes in brain hemodynamics may be associated with the main clinical AD symptoms. To test this possibility, we measured the variability of blood oxygen level-dependent (BOLD) signal in individuals from three independent datasets (totaling 80 AD patients and 90 controls). We detected a replicable increase in brain BOLD signal variability in the AD populations, which constituted a robust biomarker for clearly differentiating AD cases from controls. Fast BOLD scans showed that the elevated BOLD signal variability in AD arises mainly from cardiovascular brain pulsations. Manifesting in abnormal cerebral perfusion and cerebrospinal fluid convection, present observation presents a mechanism explaining earlier observations of impaired glymphatic clearance associated with AD in humans.
Kokoelmat
- Avoin saatavuus [34589]
